Physician
Kallwitz, Karin
Kallwitz, Karin was paid $247K by Medicaid between Jan 2018 and Dec 2024, across 14 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 41% of everything it billed.
33Billing provider infoKALLWITZ, KARIN
GRAYSLAKE, IL 60030
GRAYSLAKE, IL 60030
33aNPI1003800129assigned 09/02/2005
33bProvider typePediatric Adolescent Medicine Physician
28Total paid$247K
24GClaims4,615
24DCodes billed14
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Pediatric Adolescent Medicine Physician providers in Illinois
Rank by total paid#13 of 44
Median peer was paid$65K
This provider vs. median3.8×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 872 | $33K | |
| 2019 | 985 | $42K | |
| 2020 | 561 | $22K | |
| 2021 | 410 | $17K | |
| 2022 | 610 | $41K | |
| 2023 | 721 | $54K | |
| 2024incomplete | 456 | $37K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 41% | 2,148 | 1,927 | $101K |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 26% | 766 | 713 | $63K |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | 13% | 229 | 217 | $33K |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | 5.1% | 182 | 172 | $13K |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | 4.5% | 248 | 235 | $11K |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | 3.9% | 123 | 118 | $10K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 2.3% | 317 | 267 | $6K |
| 90686 | 1.3% | 302 | 276 | $3K | |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | 1.3% | 50 | 46 | $3K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 62 | 36 | $2K |
| 96160 | <1% | 86 | 78 | $1K | |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | <1% | 14 | 14 | $1K |
2 more codes
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.